Q2 2017 |
749 |
$30B |
+$2.09B |
-$975M |
+$1.11B |
FMX, BBD, YUMC, ASR, TS, BSAC |
13F-HR |
8/10/2017, 11:28 AM |
Q1 2017 |
739 |
$28.1B |
+$1.52B |
-$1.08B |
+$440M |
FMX, BBD, TS, ASR, YUMC, VALE |
13F-HR |
5/9/2017, 06:27 PM |
Q4 2016 |
740 |
$26.2B |
+$1.96B |
-$3.81B |
-$1.85B |
FMX, BBD, TS, ASR, YUMC, BSAC |
13F-HR |
2/6/2017, 05:57 PM |
Q3 2016 |
733 |
$28B |
+$1.25B |
-$1.14B |
+$111M |
FMX, BBD, TS, EOG, YUM, PEP |
13F-HR |
11/14/2016, 10:57 AM |
Q2 2016 |
723 |
$27.1B |
+$810M |
-$1.79B |
-$981M |
FMX, BBD, TS, EOG, PEP, YUM |
13F-HR |
8/1/2016, 10:45 AM |
Q1 2016 |
721 |
$27.6B |
+$1.43B |
-$3.41B |
-$1.98B |
FMX, BBD, TS, CVS, PEP, EOG |
13F-HR |
5/13/2016, 06:27 PM |
Q4 2015 |
724 |
$29.4B |
+$1.64B |
-$3.44B |
-$1.8B |
FMX, BBD, EOG, TS, CVS, PEP |
13F-HR |
2/9/2016, 03:44 PM |
Q3 2015 |
687 |
$29.3B |
+$1.5B |
-$2.92B |
-$1.42B |
FMX, BBD, TS, EOG, CVS, PEP |
13F-HR |
11/9/2015, 04:35 PM |
Q2 2015 |
680 |
$34.7B |
+$728M |
-$2.55B |
-$1.83B |
FMX, BBD, TS, CVS, YUM, EOG |
13F-HR |
8/12/2015, 05:30 PM |
Q1 2015 |
682 |
$37.2B |
+$2.42B |
-$2.92B |
-$499M |
FMX, BBD, TS, CVS, EOG, PEP |
13F-HR |
5/8/2015, 09:17 PM |
Q4 2014 |
687 |
$39.8B |
+$1.56B |
-$5.16B |
-$3.6B |
BBD, FMX, TS, CVS, JNJ, VALEP |
13F-HR |
1/12/2015, 06:35 PM |
Q3 2014 |
742 |
$45.3B |
+$1.44B |
-$2.3B |
-$857M |
TS, BBD, FMX, JNJ, PBRA, CVS |
RESTATEMENT |
10/22/2014, 06:32 PM |
Q2 2014 |
762 |
$47.9B |
+$13.2B |
-$2.09B |
+$11.1B |
BBD, TS, FMX, PBRA, JNJ, VALEP |
13F-HR |
7/24/2014, 11:54 AM |
Q1 2014 |
599 |
$35.8B |
+$977M |
-$1.71B |
-$735M |
BBD, TS, FMX, PBRA, JNJ, CVS |
13F-HR |
4/23/2014, 07:04 PM |
Q4 2013 |
587 |
$35.8B |
|
|
|
TS, BBD, FMX, PBRA, JNJ, CVS |
13F-HR |
1/30/2014, 05:06 PM |